Chemo Therapy Failure

A New Phase II Trial for Men with Androgen Independent Prostate Cancer After the Failure of Chemotherapy

Once we develop metastatic androgen-independent prostate cancer and experience disease progression after receiving docetaxel-based chemotherapy we have no approved treatment options. We have hit the proverbial wall! In the process of attempting to develop additional treatments, ImClone Systems Inc. (NASDAQ: IMCL), announced the beginning of a Phase II clinical trial for men with advanced prostate [...]

By Malecare|2021-02-17T11:03:15-05:00September 2nd, 2008|Advanced Prostate Cancer, Chemo Therapy, Chemo Therapy Failure, Clinical Trials, Drugs & Treatments, Uncategorized|0 Comments

Phase III Clinical Trial for OGX_011 – A Treatment for Failed Chemotherapy

At the last ASCO Annual Meeting Saad et al. presented a report about a Phase II trial of custirsen (OGX-011) + docetaxel + prednisone vs. custirsen + mitoxantrone + prednisone in metastatic hormone-refractory prostate cancer. The subjects in the study had experienced relapses of cancer progression within 6 months of treatment with first-line docetaxel therapy. [...]

By Malecare|2017-10-19T10:57:08-04:00August 23rd, 2008|Advanced Prostate Cancer, Chemo Therapy, Chemo Therapy Failure, Clinical Trials, Clinical Trials, Uncategorized|0 Comments

New York Times – In Cancer Therapy, There Is a Time to Treat and a Time to Let Go

Today’s New York Times had an article written by Jane Brody that discusses the painful issues surrounding the decision to stop treatment, and its negative side effects, and let a cancer survivor live their last weeks in relative peace. This is always a difficult decision as many of us wish to hold on to life, [...]

By Malecare|2020-02-04T10:38:19-05:00August 19th, 2008|Advanced Prostate Cancer, Chemo Therapy, Chemo Therapy Failure, Drugs & Treatments, How We Live, Uncategorized, Understanding APC|0 Comments